Page last updated: 2024-10-24

pattern recognition receptor activity

Definition

Target type: molecularfunction

Combining with a pathogen-associated molecular pattern (PAMP), a structure conserved among microbial species to initiate an innate immune response. [GOC:ar, GOC:bf]

Pattern recognition receptor (PRR) activity is a crucial component of the innate immune system, playing a pivotal role in detecting and responding to invading pathogens and danger signals. PRRs are expressed on the surface of various immune cells, such as macrophages, neutrophils, dendritic cells, and epithelial cells. They recognize highly conserved molecular patterns associated with pathogens, known as pathogen-associated molecular patterns (PAMPs), and damage-associated molecular patterns (DAMPs) released from damaged host cells.

Upon recognition of these patterns, PRRs trigger a cascade of intracellular signaling events that lead to the activation of immune responses. These responses can include the production of pro-inflammatory cytokines, the activation of phagocytosis, the induction of antimicrobial mechanisms, and the initiation of adaptive immune responses.

PRRs are classified into several families, each with its unique molecular structure and recognition specificity. The main families include:

- Toll-like receptors (TLRs): TLRs are transmembrane proteins that recognize a wide range of PAMPs and DAMPs, including bacterial lipopolysaccharide (LPS), viral double-stranded RNA (dsRNA), and fungal mannans.

- C-type lectin receptors (CLRs): CLRs are carbohydrate-binding proteins that recognize fungal cell wall components, such as mannose and glucan.

- NOD-like receptors (NLRs): NLRs are cytoplasmic proteins that detect intracellular PAMPs and DAMPs, such as bacterial peptidoglycans and intracellular pathogens.

- RIG-I-like receptors (RLRs): RLRs are cytoplasmic proteins that recognize viral RNA.

- AIM2-like receptors (ALRs): ALRs are cytoplasmic proteins that detect bacterial DNA.

The molecular mechanisms underlying PRR activation are complex and involve interactions with adaptor proteins, kinases, and transcription factors. These interactions result in the activation of downstream signaling pathways, such as the NF-κB and MAPK pathways, which ultimately lead to the production of inflammatory cytokines, chemokines, and other immune effector molecules.

In summary, PRR activity is a critical first line of defense against infection and injury, ensuring rapid recognition and response to invading pathogens and cellular damage. The diverse family of PRRs provides a broad spectrum of recognition capabilities, enabling the immune system to effectively detect and combat a wide range of threats.'
"

Proteins (6)

ProteinDefinitionTaxonomy
Toll-like receptor 8A Toll-like receptor 8 that is encoded in the genome of human. [PRO:CNA, UniProtKB:Q9NR97]Homo sapiens (human)
Toll-like receptor 7A Toll-like receptor 7 that is encoded in the genome of human. [PRO:CNA, UniProtKB:Q9NYK1]Homo sapiens (human)
Nucleotide-binding oligomerization domain-containing protein 1A nucleotide-binding oligomerization domain-containing protein 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9Y239]Homo sapiens (human)
Toll-like receptor 9A Toll-like receptor 9 that is encoded in the genome of human. []Homo sapiens (human)
Nucleotide-binding oligomerization domain-containing protein 2A nucleotide-binding oligomerization domain-containing protein 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9HC29]Homo sapiens (human)
Toll-like receptor 2A Toll-like receptor 2 that is encoded in the genome of human. [PRO:CNA]Homo sapiens (human)

Compounds (25)

CompoundDefinitionClassesRoles
palmitic acidhexadecanoic acid : A straight-chain, sixteen-carbon, saturated long-chain fatty acid.

Palmitic Acid: A common saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids.
long-chain fatty acid;
straight-chain saturated fatty acid
algal metabolite;
Daphnia magna metabolite;
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor;
plant metabolite
hydroxychloroquinehydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
aminoquinoline;
organochlorine compound;
primary alcohol;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antimalarial;
antirheumatic drug;
dermatologic drug
myristic acidMyristic Acid: A saturated 14-carbon fatty acid occurring in most animal and vegetable fats, particularly butterfat and coconut, palm, and nutmeg oils. It is used to synthesize flavor and as an ingredient in soaps and cosmetics. (From Dorland, 28th ed)

tetradecanoate : A long-chain fatty acid anion that is the conjugate base of myristic acid; major species at pH 7.3.

tetradecanoic acid : A straight-chain, fourteen-carbon, long-chain saturated fatty acid mostly found in milk fat.
long-chain fatty acid;
straight-chain saturated fatty acid
algal metabolite;
Daphnia magna metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite
paclitaxelTaxus: Genus of coniferous yew trees or shrubs, several species of which have medicinal uses. Notable is the Pacific yew, Taxus brevifolia, which is used to make the anti-neoplastic drug taxol (PACLITAXEL).taxane diterpenoid;
tetracyclic diterpenoid
antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
imiquimodimiquimod : An imidazoquinoline fused [4,5-c] carrying isobutyl and amino substituents at N-1 and C-4 respectively. A prescription medication, it acts as an immune response modifier and is used to treat genital warts, superficial basal cell carcinoma, and actinic keratosis.

Imiquimod: A topically-applied aminoquinoline immune modulator that induces interferon production. It is used in the treatment of external genital and perianal warts, superficial CARCINOMA, BASAL CELL; and ACTINIC KERATOSIS.
imidazoquinolineantineoplastic agent;
interferon inducer
docetaxel anhydrousdocetaxel anhydrous : A tetracyclic diterpenoid that is paclitaxel with the N-benzyloxycarbonyl group replaced by N-tert-butoxycarbonyl, and the acetoxy group at position 10 replaced by a hydroxy group.

Docetaxel: A semisynthetic analog of PACLITAXEL used in the treatment of locally advanced or metastatic BREAST NEOPLASMS and NON-SMALL CELL LUNG CANCER.
secondary alpha-hydroxy ketone;
tetracyclic diterpenoid
antimalarial;
antineoplastic agent;
photosensitizing agent
resiquimodS 28463: structure given in first sourceimidazoquinoline
muramyl dipeptideglycopeptideimmunological adjuvant
3-methyl-7-pentyl-8-(2-phenylethylthio)purine-2,6-dioneoxopurine
3-methyl-7-(phenylmethyl)-8-(propan-2-ylthio)purine-2,6-dioneoxopurine
1-(4-methylphenyl)sulfonyl-2-benzimidazolaminesulfonamide
1-(4-chlorophenyl)sulfonyl-2-benzimidazolaminesulfonamide
N'-[(4-chlorophenyl)-oxomethyl]-2-methyl-4-thiazolecarbohydrazidecarbonyl compound;
organohalogen compound
N'2-[3-(trifluoromethyl)benzoyl]-3-aminopyrazine-2-carbohydrazide(trifluoromethyl)benzenes
1-(benzenesulfonyl)-2-benzimidazolaminesulfonamide
1-(4-nitrophenyl)sulfonyl-2-benzimidazolaminesulfonamide
pd 166285
sm360320SM360320: Proc Natl Acad Sci U S A 2006 Feb 7;103(6):1828-33
cl 075
vtx-2337
dsr-6434DSR-6434: structure in first source
1-(4-methoxyphenyl)sulfonyl-2-benzimidazolaminesulfonamide
5,6-dimethyl-1-(4-methylphenyl)sulfonyl-2-benzimidazolaminesulfonamide
gardiquimod
gs-9620